Edition 2/2021: Tackling The Pharma Path For Optimizing Revenue Streams
Life Science companies are facing unprecedent pricing pressures and commercialed disruption due to the COVID-19 pandemic and subsequent economic crisis. In this difficult time many businesses need to find mechanisms to optimize their revenue streams. In this whitepaper we’ll analyze how moving from operational silos to full visibility helps companies to gain not only control of all their transactional processes but also how to elevate to the next level of maturity and see which decisions to take for maximizing margins. We’ll identify why many companies are stuck in asilo fragmented revenue model where processes are not harmonized and have undetected revenue leakages. Once decided for a holistic revenue management companies can obtain not only full transactional control but also move from reactive to proactive approach to further maximizing profit margins.
The EPP® Thought Leadership Series provide insights from pricing leaders around the globe. When a new insight breaks, these pricing leaders already think of the unanswered questions and the story behind the story. These people want to inspire you to act - to take the next step in your journey. With these series, we help to take the right actions
EPP Prime+ Required to access this resource
Join EPP Prime+ now and get direct access to the best resources, weekly updated with new content, webinars, dynamic talks, tools from the EPP Community.
Subscribe your team and benefit from important group discounts